Bente Vinda

5th February 2021

Watrium continues its support of London AIM-listed Distribution Finance Capital Holdings Plc (“DF Capital”) through participation in a GBP 40 million private placement.  DF Capital was recently awarded their banking licence. The net proceeds of the private placement...

Continue Reading
29th September 2020
DF Capital granted banking licence

Distribution Finance Capital Holdings plc, a niche lender providing working capital solutions to dealers and manufacturers across the UK, today announces that, following the resubmission of its banking licence application in August...

Continue Reading
23rd September 2020
Watrium temporarily on the move

While Watrium refurbish its headquarters at Kanalen 5,  Tjuvholmen in Oslo, Norway, the company will temporarily move to its Oslo Atrium office building at Dronning Eufemias gate 6A in Bjørvika in...

Continue Reading
Watrium logo
29th June 2020

2019 was an eventful year for Watrium, with several exciting new investments, overall strong development for the portfolio companies, attractive and well positioned real estate assets, and moving into 2020 from a position of strength with a robust balance sheet. The continued value creation from...

Continue Reading
28th May 2020
Watrium continues backing of Ultimovacs

Watrium continues its support of Oslo-listed Ultimovacs ASA through participation in a NOK 160 million private placement in the pharmaceutical company. Ultimovacs is developing novel immunotherapies against cancer. The net...

Continue Reading
27th September 2019
Watrium supports CMR Surgical in transforming surgery

CMR Surgical Limited, the Company developing, manufacturing and marketing the next-generation surgical robotic system, Versius®, has raised £195 million ($240 million) to fully fund the global commercialisation of the business.

Continue Reading
3rd June 2019
Watrium underwrites listing of Ultimovacs

Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer. The lead product candidate is UV1, a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen...

Continue Reading
9th May 2019
Watrium supports listing of DF Capital

Watrium supports the listing of DF Capital on AIM as cornerstone investor.

Continue Reading
Front deck on a boat
28th February 2019
Flexiteek International to acquire Wilks

Watrium’s portfolio company Flexiteek International, the global leader in synthetic teak decking and the 2G technology, has reached an agreement to acquire Wilks, manufacturer, and supplier of Dek-King synthetic teak...

Continue Reading